Chemoinformaics analysis of Scopadulcic acid B
| Molecular Weight | 438.564 | nRot | 3 |
| Heavy Atom Molecular Weight | 404.292 | nRig | 28 |
| Exact Molecular Weight | 438.241 | nRing | 5 |
| Solubility: LogS | -4.497 | nHRing | 0 |
| Solubility: LogP | 4.469 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 71.771 |
| nHD | 1 | BPOL | 38.449 |
| QED | 0.65 |
| Synth | 5.531 |
| Natural Product Likeliness | 2.439 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.133 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -5.49 |
| MDCK | 0.0000199 |
| BBB | 0.117 |
| PPB | 0.957922 |
| VDSS | 0.395 |
| FU | 0.0510757 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.521 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.815 |
| CYP2c9-inh | 0.244 |
| CYP2c9-sub | 0.323 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.055 |
| CYP3a4-inh | 0.651 |
| CYP3a4-sub | 0.215 |
| CL | 2.894 |
| T12 | 0.576 |
| hERG | 0.236 |
| Ames | 0.007 |
| ROA | 0.086 |
| SkinSen | 0.365 |
| Carcinogencity | 0.43 |
| EI | 0.075 |
| Respiratory | 0.913 |
| NR-Aromatase | 0.502 |
| Antiviral | Yes |
| Prediction | 0.920069 |